Literature DB >> 12527920

Applications of positron-emitting halogens in PET oncology (Review).

Matthias Glaser1, Sajinder K Luthra, Frank Brady.   

Abstract

The positron-emitting radiohalogens 18F, 75Br, 76Br, and 124I are reviewed regarding their relevance for positron emission tomography (PET) in oncology. Relevant production routes of these cyclotron-generated isotopes are given, followed by publications that deal with applications of these radiohalogens. This article tries to cover the whole literature for the non-conventional isotopes 75Br, 76Br, and 124I. From the literature on 18F, only articles since 2000 are considered. Here, the emphasis is also given to alternative biomarkers beyond [18]2-fluoro-2-deoxyglucose ([18F]FDG).

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12527920

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  5 in total

Review 1.  The next generation of positron emission tomography radiopharmaceuticals in oncology.

Authors:  Samuel L Rice; Celeste A Roney; Pierre Daumar; Jason S Lewis
Journal:  Semin Nucl Med       Date:  2011-07       Impact factor: 4.446

2.  Development and Preliminary Evaluation of TFIB, a New Bimodal Prosthetic Group for Bioactive Molecule Labeling.

Authors:  Emilie M F Billaud; Aurélien Vidal; Amélie Vincenot; Sophie Besse; Bernadette Bouchon; Eric Debiton; Elisabeth Miot-Noirault; Imen Miladi; Latifa Rbah-Vidal; Philippe Auzeloux; Jean-Michel Chezal
Journal:  ACS Med Chem Lett       Date:  2014-11-24       Impact factor: 4.345

3.  Harvesting krypton isotopes from the off-gas of an irradiated water target to generate 76Br and 77Br.

Authors:  Hannah K Clause; Katharina A Domnanich; Chloe Kleinfeldt; Morgan Kalman; Wesley Walker; Chirag Vyas; E Paige Abel; Gregory W Severin
Journal:  Sci Rep       Date:  2022-01-26       Impact factor: 4.379

4.  The influence of interpreters' professional background and experience on the interpretation of multimodality imaging of pulmonary lesions using 18F-3'-deoxy-fluorothymidine and 18F-fluorodeoxyglucose PET/CT.

Authors:  Bai-xuan Xu; Chang-bin Liu; Rui-min Wang; Ming-zhe Shao; Li-ping Fu; Yun-gang Li; Jia-he Tian
Journal:  PLoS One       Date:  2013-04-02       Impact factor: 3.240

5.  The diagnostic value of 124I-PET in patients with differentiated thyroid cancer.

Authors:  Ha T T Phan; Pieter L Jager; Anne M J Paans; John T M Plukker; M G G Sturkenboom; W J Sluiter; Bruce H R Wolffenbuttel; Rudi A J O Dierckx; Thera P Links
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-01-04       Impact factor: 9.236

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.